[Table/Fig-8]:
Antimicrobial resistance pattern of enterobacteriacae GNB.
| Antimicrobial agent | Escherichia coli (457) | Klebsiella spp (456) | Enterobacter spp (143) | Proteeae tribe (74) | Citrobacter spp (27) |
|---|---|---|---|---|---|
| Ceftriaxone | 411 (89.9%) | 381(83.5%) | 125(87.4%) | 52(70.3%) | 21(77.8%) |
| Ceftazidime | 389(85.1%) | 377(82.7%) | 121(84.6%) | 50(67.6%) | 23(85.2%) |
| Cefoperazone/ Sulbactam | 61(13.3%) | 80(17.5%) | 26(18.2%) | 7(9.5%) | 4(14.8%) |
| Meropenem | 99(21.6%) | 204(44.7%) | 73(51.1%) | 7(9.5%) | 10(37%) |
| Gentamycin | 292(63.9%) | 311(68.2%) | 109(76.2%) | 47(63.5%) | 18(66.6%) |
| Amikacin | 109(23.9%) | 221(48.4%) | 83(58%) | 40(54.1%) | 16(59.3%) |
| Ciprofloxacin | 412(90.1%) | 358(78.5%) | 110(77%) | 57(77%) | 20(74.1%) |
*% indicates resistance of a clinical isolate to corresponding antimicrobial agen